Kovaleva N, Kusmartsev F, Mekhiya A, Trunkin I, Chvostova D, Davydov A
Sci Rep. 2020; 10(1):21172.
PMID: 33273549
PMC: 7713312.
DOI: 10.1038/s41598-020-78185-6.
Istrate C, Hagbom M, Vikstrom E, Magnusson K, Svensson L
J Virol. 2013; 88(6):3161-9.
PMID: 24371070
PMC: 3957942.
DOI: 10.1128/JVI.02927-13.
Alam N, Ashraf H, Olesen M, Salam M, Gyr N, Meier R
J Health Popul Nutr. 2011; 29(4):297-302.
PMID: 21957667
PMC: 3190359.
DOI: 10.3329/jhpn.v29i4.8443.
Gessell-Lee D, Popov V, Boldogh I, Olano J, Peterson J
Infect Immun. 2003; 71(11):6234-42.
PMID: 14573642
PMC: 219558.
DOI: 10.1128/IAI.71.11.6234-6242.2003.
Alam N, Ashraf H, Khan W, Karim M, FUCHS G
Gut. 2003; 52(10):1419-23.
PMID: 12970133
PMC: 1773819.
DOI: 10.1136/gut.52.10.1419.
Role of platelet-activating factor in Chinese hamster ovary cell responses to cholera toxin.
Thielman N, Marcinkiewicz M, Sarosiek J, Fang G, Guerrant R
J Clin Invest. 1997; 99(8):1999-2004.
PMID: 9109445
PMC: 508025.
DOI: 10.1172/JCI119368.
Role of platelet activating factor in the intestinal epithelial secretory and Chinese hamster ovary cell cytoskeletal responses to cholera toxin.
Guerrant R, Fang G, Thielman N, Fonteles M
Proc Natl Acad Sci U S A. 1994; 91(20):9655-8.
PMID: 7937824
PMC: 44872.
DOI: 10.1073/pnas.91.20.9655.
Effects of salicylate on intestinal absorption: in vitro and in vivo studies with enterotoxigenic micro-organisms.
Burke V, Gracey M
Gut. 1980; 21(8):683-8.
PMID: 7429332
PMC: 1419111.
DOI: 10.1136/gut.21.8.683.
Do prostaglandins cause gastrointestinal mucosal injury?.
Northway M, Castell D
Dig Dis Sci. 1981; 26(5):453-6.
PMID: 7249885
DOI: 10.1007/BF01313590.
Drugs in the treatment of diarrheas.
Walia B, Agrawal S, Aggarwal K, Panhotra B, Manchanda K
Indian J Pediatr. 1980; 47(387):323-7.
PMID: 7228231
DOI: 10.1007/BF02831328.
Effect of lodoxamide on the secretory response induced by Escherichia coli and Vibrio cholerae enterotoxins in infant mice.
Knoop F, Thomas D
Infect Immun. 1984; 44(2):406-8.
PMID: 6143729
PMC: 263533.
DOI: 10.1128/iai.44.2.406-408.1984.
Inhibition of Escherichia coli heat-stable enterotoxin by indomethacin and chlorpromazine.
Greenberg R, Murad F, Chang B, ROBERTSON D, Guerrant R
Infect Immun. 1980; 29(3):908-13.
PMID: 6107277
PMC: 551217.
DOI: 10.1128/iai.29.3.908-913.1980.
Further observations on mesenteric vasoconstriction, survival and the clotting defect after endotoxin administration.
COHEN M, GREENWAY C, Innes I, Lister G, Murthy V, SCOTT G
Br J Pharmacol. 1973; 48(4):555-69.
PMID: 4788202
PMC: 1776160.
DOI: 10.1111/j.1476-5381.1973.tb08242.x.
Prostaglandins and the gastrointestinal tract.
Waller S
Gut. 1973; 14(5):402-17.
PMID: 4577412
PMC: 1412701.
DOI: 10.1136/gut.14.5.402.
The hyperthermic effect of intracerebroventricular cholera enterotoxin in the unanaesthetized cat.
Clark W, Cumby H, Davis 4th N
J Physiol. 1974; 240(2):493-504.
PMID: 4371060
PMC: 1331025.
DOI: 10.1113/jphysiol.1974.sp010619.
The pathogenesis of cholera and some wider implications.
Sladen G
Gut. 1973; 14(8):671-80.
PMID: 4360063
PMC: 1412753.
DOI: 10.1136/gut.14.8.671.
Effects of prostaglandins and cholera enterotoxin on intestinal mucosal cyclic AMP accumulation. Evidence against an essential role for prostaglandins in the action of toxin.
KIMBERG D, Field M, Gershon E, Henderson A
J Clin Invest. 1974; 53(3):941-9.
PMID: 4359941
PMC: 333077.
DOI: 10.1172/JCI107635.
Prostaglandins are not mediators of the intestinal response to cholera toxin.
Smith G, Warhurst G, Tonge A, Turnberg L
Gut. 1985; 26(7):680-2.
PMID: 3860458
PMC: 1433008.
DOI: 10.1136/gut.26.7.680.
Increased jejunal prostaglandin E2 concentrations in patients with acute cholera.
Speelman P, Rabbani G, Bukhave K, Rask-Madsen J
Gut. 1985; 26(2):188-93.
PMID: 3855402
PMC: 1432427.
DOI: 10.1136/gut.26.2.188.
Antidiarrheal therapy. Prospects for new agents.
Fedorak R, Field M
Dig Dis Sci. 1987; 32(2):195-205.
PMID: 3542447
DOI: 10.1007/BF01297108.
